The current earnings forecast score of Henry Schein Inc is 7.37, ranking 142 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 78.00, with a high of 90.00 and a low of 58.00.
Analyst Rating
Based on
19
analysts
Buy
Current Rating
87.757
Target Price
+2.68%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Henry Schein Inc
HSIC
19
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Henry Schein Inc's expected revenue for the next quarter?
Henry Schein Inc's expected revenue is 3.37B.
What is Henry Schein Inc's price target?
Analysts forecast that Henry Schein Inc's price target is USD 78.00, with the highest forecast at USD 90.00 and the lowest forecast at USD 58.00.
How have Henry Schein IncHSIC's recent earnings per share performed?
The market expectation was USD 0.93, while Henry Schein IncHSIC's earnings per share (EPS) for the previous quarter was USD 0.86. EPS for the next quarter is expected at USD 1.24.
What is the analyst rating for Henry Schein Inc?
Based on the ratings of Henry Schein Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.